Financhill
Sell
5

FOXX Quote, Financials, Valuation and Earnings

Last price:
$5.50
Seasonality move :
--
Day range:
$5.44 - $6.26
52-week range:
$2.89 - $12.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
36.4K
Avg. volume:
198.1K
1-year change:
--
Market cap:
$39.2M
Revenue:
$21.6M
EPS (TTM):
--
Period Ending 2019-06-30 2020-06-30 2021-06-30 2022-06-30 2023-06-30
Revenue -- -- -- $12.9M $21.6M
Revenue Growth (YoY) -- -- -- -- 67.7%
 
Cost of Revenues -- -- -- $12.4M $20.5M
Gross Profit -- -- -- $454.6K $1.1M
Gross Profit Margin -- -- -- 3.53% 5.13%
 
R&D Expenses -- -- -- -- $272.1K
Selling, General & Admin -- -- -- $423K $750.5K
Other Inc / (Exp) -- -- -- $114.6K -$4.5K
Operating Expenses -- -- -- $423K $1M
Operating Income -- -- -- $31.6K $86.2K
 
Net Interest Expenses -- -- -- -- $9.3K
EBT. Incl. Unusual Items -- -- -- $146.2K $72.4K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $1.6K $14.2K
Net Income to Company -- -- -- $144.6K $58.2K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $144.6K $58.2K
 
Basic EPS (Cont. Ops) -- -- -- $0.02 $0.01
Diluted EPS (Cont. Ops) -- -- -- $0.02 $0.01
Weighted Average Basic Share -- -- -- $7.2M $7.2M
Weighted Average Diluted Share -- -- -- $7.2M $7.2M
 
EBITDA -- -- -- $146.5K $102.5K
EBIT -- -- -- $146.2K $81.7K
 
Revenue (Reported) -- -- -- $12.9M $21.6M
Operating Income (Reported) -- -- -- $31.6K $86.2K
Operating Income (Adjusted) -- -- -- $146.2K $81.7K
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue -- -- -- $6.5M $513.8K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $6.1M $553.5K
Gross Profit -- -- -- $367.3K -$39.7K
Gross Profit Margin -- -- -- 5.65% -7.72%
 
R&D Expenses -- -- -- $112K $45.6K
Selling, General & Admin -- -- -- $205.8K $707.3K
Other Inc / (Exp) -- -- -- -- $3.4K
Operating Expenses -- -- -- $317.8K $752.9K
Operating Income -- -- -- $49.5K -$792.6K
 
Net Interest Expenses -- -- -- $1.5K $77.6K
EBT. Incl. Unusual Items -- -- -- $48.1K -$866.7K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $8K $19.8K
Net Income to Company -- -- -- $276.7K -$2.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $40.1K -$886.6K
 
Basic EPS (Cont. Ops) -- -- -- $0.01 -$0.12
Diluted EPS (Cont. Ops) -- -- -- $0.01 -$0.12
Weighted Average Basic Share -- -- -- $7.2M $7.2M
Weighted Average Diluted Share -- -- -- $7.2M $7.2M
 
EBITDA -- -- -- $57.2K -$768.7K
EBIT -- -- -- $49.5K -$789.2K
 
Revenue (Reported) -- -- -- $6.5M $513.8K
Operating Income (Reported) -- -- -- $49.5K -$792.6K
Operating Income (Adjusted) -- -- -- $49.5K -$789.2K
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- $3.4K
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $1.5K $86.9K
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue -- -- -- $6.5M $513.8K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $6.1M $553.5K
Gross Profit -- -- -- $367.3K -$39.7K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $112K $45.6K
Selling, General & Admin -- -- -- $205.8K $707.3K
Other Inc / (Exp) -- -- -- -- $3.4K
Operating Expenses -- -- -- $317.8K $752.9K
Operating Income -- -- -- $49.5K -$792.6K
 
Net Interest Expenses -- -- -- $1.5K $77.6K
EBT. Incl. Unusual Items -- -- -- $48.1K -$866.7K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $8K $19.8K
Net Income to Company -- -- -- $276.7K -$2.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $40.1K -$886.6K
 
Basic EPS (Cont. Ops) -- -- -- $0.01 -$0.12
Diluted EPS (Cont. Ops) -- -- -- $0.01 -$0.12
Weighted Average Basic Share -- -- -- $7.2M $7.2M
Weighted Average Diluted Share -- -- -- $7.2M $7.2M
 
EBITDA -- -- -- $57.2K -$768.7K
EBIT -- -- -- $49.5K -$789.2K
 
Revenue (Reported) -- -- -- $6.5M $513.8K
Operating Income (Reported) -- -- -- $49.5K -$792.6K
Operating Income (Adjusted) -- -- -- $49.5K -$789.2K
Period Ending 2019-06-30 2020-06-30 2021-06-30 2022-06-30 2023-06-30
Cash and Equivalents -- -- -- $21.7K $1.8M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $11.4K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $605.6K $1.8M
 
Property Plant And Equipment -- -- -- $280 $173.7K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $605.9K $2M
 
Accounts Payable -- -- -- $84.9K --
Accrued Expenses -- -- -- -- $3.5K
Current Portion Of Long-Term Debt -- -- -- $536.8K $2.4M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $1.2M $2.5M
 
Long-Term Debt -- -- -- -- $115K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $1.2M $2.6M
 
Common Stock -- -- -- $1K $1K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -$630K -$571.8K
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -$630K -$571.8K
 
Total Liabilities and Equity -- -- -- $605.9K $2M
Cash and Short Terms -- -- -- $21.7K $1.8M
Total Debt -- -- -- $536.8K $2.5M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents -- -- -- -- $254.8K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- $175K
Inventory -- -- -- -- $662.2K
Prepaid Expenses -- -- -- -- $11.6K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- -- $2.8M
 
Property Plant And Equipment -- -- -- -- $262.6K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- $3.3M
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- $162.9K
Current Portion Of Long-Term Debt -- -- -- -- $5.3M
Current Portion Of Capital Lease Obligations -- -- -- -- $40.6K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- $5.8M
 
Long-Term Debt -- -- -- -- $100.6K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $6M
 
Common Stock -- -- -- -- $1K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- -$2.6M
 
Total Liabilities and Equity -- -- -- -- $3.3M
Cash and Short Terms -- -- -- -- $254.8K
Total Debt -- -- -- -- $5.4M
Period Ending 2019-06-30 2020-06-30 2021-06-30 2022-06-30 2023-06-30
Net Income to Stockholders -- -- -- $144.6K $58.2K
Depreciation & Amoritzation -- -- -- $310 $20.8K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$287.1K $30.2K
 
Capital Expenditures -- -- -- -- $66.9K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$66.9K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $239K $2M
Long-Term Debt Repaid -- -- -- -- -$160.2K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $279K $1.8M
 
Beginning Cash (CF) -- -- -- $29.8K $21.7K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$8.1K $1.8M
Ending Cash (CF) -- -- -- $21.7K $1.8M
 
Levered Free Cash Flow -- -- -- -$287K -$36.7K
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- $276.7K -$2.1M
Depreciation & Amoritzation -- -- -- $11.1K $50.5K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- -$175K
Change in Inventories -- -- -- -- -$662.2K
Cash From Operations -- -- -- $200.2K -$4.3M
 
Capital Expenditures -- -- -- $66.9K $7.1K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$66.9K -$7.1K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $3M
Long-Term Debt Repaid -- -- -- -$154.8K -$102.7K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$209.7K
Cash From Financing -- -- -- -$154.8K $2.7M
 
Beginning Cash (CF) -- -- -- $21.7K $1.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$21.5K -$1.6M
Ending Cash (CF) -- -- -- $270 $254.8K
 
Levered Free Cash Flow -- -- -- $133.3K -$4.3M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- $66.9K $74K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- $276.7K -$2.1M
Depreciation & Amoritzation -- -- -- $11.1K $50.5K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- -$175K
Change in Inventories -- -- -- -- -$662.2K
Cash From Operations -- -- -- $200.2K -$4.3M
 
Capital Expenditures -- -- -- $66.9K $7.1K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$66.9K -$7.1K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $3M
Long-Term Debt Repaid -- -- -- -$154.8K -$102.7K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$209.7K
Cash From Financing -- -- -- -$154.8K $2.7M
 
Beginning Cash (CF) -- -- -- $21.7K $1.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$21.5K -$1.6M
Ending Cash (CF) -- -- -- $270 $254.8K
 
Levered Free Cash Flow -- -- -- $133.3K -$4.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock